Concepedia

Publication | Closed Access

Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors

DOI

10

Citations

23

References

2020

Year

Jean‐Pierre Delord, Antoîne Italiano, Ahmad Awada, Philippe Aftimos, Nadine Houédé, Célèste Lebbé, Céline Pagès, Thierry Lesimple, Monica Dinulescu, Jan H.M. Schellens,
Targeted Oncology

References

YearCitations

Page 1